Global Immuno-Oncology Market Growth (Status and Outlook) 2025-2031

January 2025 | 94 pages | ID: G1DB0B1CF0FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Immuno-Oncology market size is predicted to grow from US$ 56260 million in 2025 to US$ 133260 million in 2031; it is expected to grow at a CAGR of 15.5% from 2025 to 2031.

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

LPI (LP Information)' newest research report, the “Immuno-Oncology Industry Forecast” looks at past sales and reviews total world Immuno-Oncology sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology sales for 2025 through 2031. With Immuno-Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology industry.

This Insight Report provides a comprehensive analysis of the global Immuno-Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno-Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immune Checkpoint Inhibitors
• Cytokine-Based Immunotherapy
• Cancer Vaccines
• CAR-T Cell Therapy
• Others

Segmentation by Application:

• Hospitals
• Drugstores
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol-Myers Squibb
• Merck & Co., Inc.
• Roche AG
• AstraZeneca, Plc
• Sanofi S.A.
• Dendreon Pharmaceuticals
• Novartis
• Gilead Sciences Inc.
• Merck KGaA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immuno-Oncology Market Size (2020-2031)
  2.1.2 Immuno-Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Immuno-Oncology by Country/Region (2020, 2024 & 2031)
2.2 Immuno-Oncology Segment by Type
  2.2.1 Immune Checkpoint Inhibitors
  2.2.2 Cytokine-Based Immunotherapy
  2.2.3 Cancer Vaccines
  2.2.4 CAR-T Cell Therapy
  2.2.5 Others
2.3 Immuno-Oncology Market Size by Type
  2.3.1 Immuno-Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Immuno-Oncology Market Size Market Share by Type (2020-2025)
2.4 Immuno-Oncology Segment by Application
  2.4.1 Hospitals
  2.4.2 Drugstores
  2.4.3 Others
2.5 Immuno-Oncology Market Size by Application
  2.5.1 Immuno-Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Immuno-Oncology Market Size Market Share by Application (2020-2025)

3 IMMUNO-ONCOLOGY MARKET SIZE BY PLAYER

3.1 Immuno-Oncology Market Size Market Share by Player
  3.1.1 Global Immuno-Oncology Revenue by Player (2020-2025)
  3.1.2 Global Immuno-Oncology Revenue Market Share by Player (2020-2025)
3.2 Global Immuno-Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMMUNO-ONCOLOGY BY REGION

4.1 Immuno-Oncology Market Size by Region (2020-2025)
4.2 Global Immuno-Oncology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immuno-Oncology Market Size Growth (2020-2025)
4.4 APAC Immuno-Oncology Market Size Growth (2020-2025)
4.5 Europe Immuno-Oncology Market Size Growth (2020-2025)
4.6 Middle East & Africa Immuno-Oncology Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Immuno-Oncology Market Size by Country (2020-2025)
5.2 Americas Immuno-Oncology Market Size by Type (2020-2025)
5.3 Americas Immuno-Oncology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immuno-Oncology Market Size by Region (2020-2025)
6.2 APAC Immuno-Oncology Market Size by Type (2020-2025)
6.3 APAC Immuno-Oncology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Immuno-Oncology Market Size by Country (2020-2025)
7.2 Europe Immuno-Oncology Market Size by Type (2020-2025)
7.3 Europe Immuno-Oncology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immuno-Oncology by Region (2020-2025)
8.2 Middle East & Africa Immuno-Oncology Market Size by Type (2020-2025)
8.3 Middle East & Africa Immuno-Oncology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMMUNO-ONCOLOGY MARKET FORECAST

10.1 Global Immuno-Oncology Forecast by Region (2026-2031)
  10.1.1 Global Immuno-Oncology Forecast by Region (2026-2031)
  10.1.2 Americas Immuno-Oncology Forecast
  10.1.3 APAC Immuno-Oncology Forecast
  10.1.4 Europe Immuno-Oncology Forecast
  10.1.5 Middle East & Africa Immuno-Oncology Forecast
10.2 Americas Immuno-Oncology Forecast by Country (2026-2031)
  10.2.1 United States Market Immuno-Oncology Forecast
  10.2.2 Canada Market Immuno-Oncology Forecast
  10.2.3 Mexico Market Immuno-Oncology Forecast
  10.2.4 Brazil Market Immuno-Oncology Forecast
10.3 APAC Immuno-Oncology Forecast by Region (2026-2031)
  10.3.1 China Immuno-Oncology Market Forecast
  10.3.2 Japan Market Immuno-Oncology Forecast
  10.3.3 Korea Market Immuno-Oncology Forecast
  10.3.4 Southeast Asia Market Immuno-Oncology Forecast
  10.3.5 India Market Immuno-Oncology Forecast
  10.3.6 Australia Market Immuno-Oncology Forecast
10.4 Europe Immuno-Oncology Forecast by Country (2026-2031)
  10.4.1 Germany Market Immuno-Oncology Forecast
  10.4.2 France Market Immuno-Oncology Forecast
  10.4.3 UK Market Immuno-Oncology Forecast
  10.4.4 Italy Market Immuno-Oncology Forecast
  10.4.5 Russia Market Immuno-Oncology Forecast
10.5 Middle East & Africa Immuno-Oncology Forecast by Region (2026-2031)
  10.5.1 Egypt Market Immuno-Oncology Forecast
  10.5.2 South Africa Market Immuno-Oncology Forecast
  10.5.3 Israel Market Immuno-Oncology Forecast
  10.5.4 Turkey Market Immuno-Oncology Forecast
10.6 Global Immuno-Oncology Forecast by Type (2026-2031)
10.7 Global Immuno-Oncology Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Immuno-Oncology Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb
  11.1.1 Bristol-Myers Squibb Company Information
  11.1.2 Bristol-Myers Squibb Immuno-Oncology Product Offered
  11.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bristol-Myers Squibb Main Business Overview
  11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Merck & Co., Inc.
  11.2.1 Merck & Co., Inc. Company Information
  11.2.2 Merck & Co., Inc. Immuno-Oncology Product Offered
  11.2.3 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Merck & Co., Inc. Main Business Overview
  11.2.5 Merck & Co., Inc. Latest Developments
11.3 Roche AG
  11.3.1 Roche AG Company Information
  11.3.2 Roche AG Immuno-Oncology Product Offered
  11.3.3 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Roche AG Main Business Overview
  11.3.5 Roche AG Latest Developments
11.4 AstraZeneca, Plc
  11.4.1 AstraZeneca, Plc Company Information
  11.4.2 AstraZeneca, Plc Immuno-Oncology Product Offered
  11.4.3 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AstraZeneca, Plc Main Business Overview
  11.4.5 AstraZeneca, Plc Latest Developments
11.5 Sanofi S.A.
  11.5.1 Sanofi S.A. Company Information
  11.5.2 Sanofi S.A. Immuno-Oncology Product Offered
  11.5.3 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi S.A. Main Business Overview
  11.5.5 Sanofi S.A. Latest Developments
11.6 Dendreon Pharmaceuticals
  11.6.1 Dendreon Pharmaceuticals Company Information
  11.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Offered
  11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Dendreon Pharmaceuticals Main Business Overview
  11.6.5 Dendreon Pharmaceuticals Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Immuno-Oncology Product Offered
  11.7.3 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 Gilead Sciences Inc.
  11.8.1 Gilead Sciences Inc. Company Information
  11.8.2 Gilead Sciences Inc. Immuno-Oncology Product Offered
  11.8.3 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Gilead Sciences Inc. Main Business Overview
  11.8.5 Gilead Sciences Inc. Latest Developments
11.9 Merck KGaA
  11.9.1 Merck KGaA Company Information
  11.9.2 Merck KGaA Immuno-Oncology Product Offered
  11.9.3 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck KGaA Main Business Overview
  11.9.5 Merck KGaA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Immuno-Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Immuno-Oncology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Cytokine-Based Immunotherapy
Table 5. Major Players of Cancer Vaccines
Table 6. Major Players of CAR-T CellTherapy
Table 7. Major Players of Others
Table 8. Immuno-Oncology Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Immuno-Oncology Market Size byType (2020-2025) & ($ millions)
Table 10. Global Immuno-Oncology Market Size Market Share byType (2020-2025)
Table 11. Immuno-Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Immuno-Oncology Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Immuno-Oncology Market Size Market Share by Application (2020-2025)
Table 14. Global Immuno-Oncology Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Immuno-Oncology Revenue Market Share by Player (2020-2025)
Table 16. Immuno-Oncology Key Players Head office and Products Offered
Table 17. Immuno-Oncology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Immuno-Oncology Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Immuno-Oncology Market Size Market Share by Region (2020-2025)
Table 22. Global Immuno-Oncology Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Immuno-Oncology Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Immuno-Oncology Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Immuno-Oncology Market Size Market Share by Country (2020-2025)
Table 26. Americas Immuno-Oncology Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Immuno-Oncology Market Size Market Share byType (2020-2025)
Table 28. Americas Immuno-Oncology Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Immuno-Oncology Market Size Market Share by Application (2020-2025)
Table 30. APAC Immuno-Oncology Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Immuno-Oncology Market Size Market Share by Region (2020-2025)
Table 32. APAC Immuno-Oncology Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Immuno-Oncology Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Immuno-Oncology Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Immuno-Oncology Market Size Market Share by Country (2020-2025)
Table 36. Europe Immuno-Oncology Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Immuno-Oncology Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Immuno-Oncology Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Immuno-Oncology Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Immuno-Oncology Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Immuno-Oncology
Table 42. Key Market Challenges & Risks of Immuno-Oncology
Table 43. Key IndustryTrends of Immuno-Oncology
Table 44. Global Immuno-Oncology Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Immuno-Oncology Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Immuno-Oncology Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Immuno-Oncology Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Bristol-Myers Squibb Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 49. Bristol-Myers Squibb Immuno-Oncology Product Offered
Table 50. Bristol-Myers Squibb Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Bristol-Myers Squibb Main Business
Table 52. Bristol-Myers Squibb Latest Developments
Table 53. Merck & Co., Inc. Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 54. Merck & Co., Inc. Immuno-Oncology Product Offered
Table 55. Merck & Co., Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Merck & Co., Inc. Main Business
Table 57. Merck & Co., Inc. Latest Developments
Table 58. Roche AG Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 59. Roche AG Immuno-Oncology Product Offered
Table 60. Roche AG Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Roche AG Main Business
Table 62. Roche AG Latest Developments
Table 63. AstraZeneca, Plc Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 64. AstraZeneca, Plc Immuno-Oncology Product Offered
Table 65. AstraZeneca, Plc Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. AstraZeneca, Plc Main Business
Table 67. AstraZeneca, Plc Latest Developments
Table 68. Sanofi S.A. Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 69. Sanofi S.A. Immuno-Oncology Product Offered
Table 70. Sanofi S.A. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Sanofi S.A. Main Business
Table 72. Sanofi S.A. Latest Developments
Table 73. Dendreon Pharmaceuticals Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 74. Dendreon Pharmaceuticals Immuno-Oncology Product Offered
Table 75. Dendreon Pharmaceuticals Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Dendreon Pharmaceuticals Main Business
Table 77. Dendreon Pharmaceuticals Latest Developments
Table 78. Novartis Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 79. Novartis Immuno-Oncology Product Offered
Table 80. Novartis Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Gilead Sciences Inc. Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 84. Gilead Sciences Inc. Immuno-Oncology Product Offered
Table 85. Gilead Sciences Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Gilead Sciences Inc. Main Business
Table 87. Gilead Sciences Inc. Latest Developments
Table 88. Merck KGaA Details, CompanyType, Immuno-Oncology Area Served and Its Competitors
Table 89. Merck KGaA Immuno-Oncology Product Offered
Table 90. Merck KGaA Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Merck KGaA Main Business
Table 92. Merck KGaA Latest Developments



LIST OFFIGURES

Figure 1. Immuno-Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Immuno-Oncology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Immuno-Oncology Sales Market Share by Country/Region (2024)
Figure 8. Immuno-Oncology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Immuno-Oncology Market Size Market Share byType in 2024
Figure 10. Immuno-Oncology in Hospitals
Figure 11. Global Immuno-Oncology Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Immuno-Oncology in Drugstores
Figure 13. Global Immuno-Oncology Market: Drugstores (2020-2025) & ($ millions)
Figure 14. Immuno-Oncology in Others
Figure 15. Global Immuno-Oncology Market: Others (2020-2025) & ($ millions)
Figure 16. Global Immuno-Oncology Market Size Market Share by Application in 2024
Figure 17. Global Immuno-Oncology Revenue Market Share by Player in 2024
Figure 18. Global Immuno-Oncology Market Size Market Share by Region (2020-2025)
Figure 19. Americas Immuno-Oncology Market Size 2020-2025 ($ millions)
Figure 20. APAC Immuno-Oncology Market Size 2020-2025 ($ millions)
Figure 21. Europe Immuno-Oncology Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Immuno-Oncology Market Size 2020-2025 ($ millions)
Figure 23. Americas Immuno-Oncology Value Market Share by Country in 2024
Figure 24. United States Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Immuno-Oncology Market Size Market Share by Region in 2024
Figure 29. APAC Immuno-Oncology Market Size Market Share byType (2020-2025)
Figure 30. APAC Immuno-Oncology Market Size Market Share by Application (2020-2025)
Figure 31. China Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 35. India Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Immuno-Oncology Market Size Market Share by Country in 2024
Figure 38. Europe Immuno-Oncology Market Size Market Share byType (2020-2025)
Figure 39. Europe Immuno-Oncology Market Size Market Share by Application (2020-2025)
Figure 40. Germany Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 41.France Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Immuno-Oncology Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Immuno-Oncology Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Immuno-Oncology Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Immuno-Oncology Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 54. APAC Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 55. Europe Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 57. United States Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 58. Canada Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 59. Mexico Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 60. Brazil Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 61. China Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 62. Japan Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 63. Korea Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 65. India Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 66. Australia Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 67. Germany Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 68.France Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 69. UK Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 70. Italy Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 71. Russia Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 72. Egypt Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 73. South Africa Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 74. Israel Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 75.Turkey Immuno-Oncology Market Size 2026-2031 ($ millions)
Figure 76. Global Immuno-Oncology Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Immuno-Oncology Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Immuno-Oncology Market Size 2026-2031 ($ millions)